🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › New Jersey

Etid klinik pou Dyabèt Tip 2 nan New Jersey

15 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan New Jersey.

Vil nan New Jersey

Tèks ofisyèl etid la (Anglè)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Advanced Heart Care, LLC, Bridgewater
  • NJ Heart LLC, Linden
  • Cardio Metabolic Institute, Somerset
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Advanced Heart and Vascular Institute of Hunterdon, Flemington
  • Virtua Health, Inc., Marlton
  • Rutgers State University, New Brunswick
  • ak 2 plis
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Hypertension & Nephrology Association, Eatontown
  • IMA Clinical Research Warren, Warren Township
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Eatontown
  • Research Site, Somerset
  • Research Site, Warren Township
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Jersey City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • Hassman Research Institute - Berlin - CenExel - PPDS, Berlin
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Clinical Research of Philadelphia, Pennington
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Premier Research, Trenton
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Premier Research, Trenton
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy

  • Rutgers Health Family Medicine at Monument Square, New Brunswick
  • University Medical Group General Internal Medicine, New Brunswick
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Jul 2, 2026 · NCT06814184

Exercise and Intranasal Insulin in Type 2 Diabetes

  • Robert Wood Johnson University Hospital Clinical Research Center, New Brunswick
  • Institute for Food, Nutrition, and Health, New Brunswick
  • Rutgers University Loree Gymnasium, New Brunswick
  • ak 1 plis
Ap rekriteFaz 2/3
Laj 55 a 80 · Tout sèks · Mizajou Jun 30, 2026 · NCT07675499

Extracellular Vesicles, Insulin Action, and Exercise

  • Institute for Food, Nutrition, and Health, New Brunswick
  • Robert Wood Johnson University Hospital Clinical Research Center, New Brunswick
  • Rutgers University Loree Gymnasium, New Brunswick
Ap rekriteVolontè an sante akeyi
Laj 30 a 80 · Tout sèks · Mizajou Jan 23, 2026 · NCT06546085

CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

  • Jefferson Health New Jersey, Sewell
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Oct 14, 2025 · NCT07184775

Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients

  • One Robert Wood Johnson Place, New Brunswick
  • One Robert Wood Johnson Place, New Brunswick
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2024 · NCT06663813

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.